Status and phase
Conditions
Treatments
About
Same patients with dilated myocardiopathies with large areas of fibrosis has not been as successful after Cardiac Resynchronization Therapy, for Heart Failure patients in functional class III or IV. Therefore the investigators have decided to associate the Stem-Cell implant with Cardiac Resynchronization Therapy in these patients.
Full description
About 120cc of blood are collected from the iliac bone marrow under epidural anesthesia.In the cell therapy lab this blood is harvested and mononuclear cells are separated.This procedure takes roughly 4 hours.After dilution the mononuclear cells are injected into the cardiac muscles with fibroses area through 20 shots.This procedure is indicated for patients with cardiac ischemia and left ventricular dysfunction(desynchrony), on whom all the others known therapies have failed.
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
Loading...
Central trial contact
Ana Carolina de Abreu, MD; Oswaldo Tadeu Greco, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal